PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

Ann: NWR Virtual Healthcare Conference Presentation, page-9

  1. bar
    666 Posts.
    lightbulb Created with Sketch. 102
    Positive MRI findings in the 6 month 008 trial should prove some DMOAD capability and be understood by the layman. If you pain is diminished significantly and you have MRI evidence of less pathology its disease modifying IMHO.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $104.9M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $161.3K 527.5K

Buyers (Bids)

No. Vol. Price($)
2 10756 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 62010 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.